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Background: Aboriginal people living in Canada have a high prevalence of obesity, type 2 diabetes, and
cardiovascular disease (CVD). To better understand the pre and postnatal influences on the development of
adiposity and related cardio-metabolic factors in adult Aboriginal people, we will recruit and follow prospectively
Aboriginal pregnant mothers and their children – the Aboriginal Birth Cohort (ABC) study.
Methods/design: We aim to recruit 300 Aboriginal pregnant mothers and their newborns from the Six Nations
Reserve, and follow them prospectively to age 3 years. Key details of environment and health including maternal
nutrition, glucose tolerance, physical activity, and weight gain will be collected. At birth, cord blood and placenta
samples will be collected, as well as newborn anthropometric measurements. Mothers and offspring will be
followed annually with serial measurements of diet and physical activity, growth trajectory, and adiposity.
Discussion: There is an urgent need to understand maternal and child factors that underlie the early development
of adiposity and type 2 diabetes in Aboriginal people. The information generated from this cohort will assist the Six
Nations community in developing interventions to prevent early adiposity in Aboriginal children.
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People of Aboriginal ancestry are a rapidly growing popu-
lation in Canada. There are over 1.2 million Aboriginal
people living in Canada, and the birth rate among Abori-
ginal people is 1.5 times that of the general population [1].
Aboriginal adults suffer a high prevalence of obesity, type
2 diabetes, and cardiovascular disease (CVD) compared to
their non-Aboriginal counterparts [2]. Furthermore, the
prevalence of type 2 diabetes among Aboriginal youth is
disproportionately higher compared to other youth in
Canada [3]. The increased prevalence of obesity and dia-
betes among Aboriginal people is highly correlated with* Correspondence: anands@mcmaster.ca
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reproduction in any medium, provided the ortheir adoption of western lifestyle practices (i.e. high en-
ergy intake and low physical activity). However, emerging
evidence suggests that the propensity to develop obesity
and type 2 diabetes is influenced by both the pre and post-
natal environment which shapes developmental growth
trajectories throughout the offsprings’ life [4].
To better understand the pre and postnatal influences
on the development of adiposity and related cardio-
metabolic factors (i.e. abnormal glucose, insulin, blood
pressure, and lipids) in Aboriginal people, we propose to
recruit and follow prospectively Aboriginal pregnant
mothers and their offspring from the Six Nations Reserve
near Brantford, Ontario and surrounding areas. This Abo-
riginal birth cohort (ABC) study will enhance our under-
standing of the determinants of adiposity, type 2 diabetes
and related cardio-metabolic factors in Aboriginal people,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vention strategies for this high-risk group.
Study rationale
Aboriginal people of the Six Nations
The Six Nations Reserve in Brant County, Ontario,
Canada took its present form of 20,000 hectares in 1847,
and is now home to over 12,000 Aboriginal people [5].
The traditional lifestyle of the Six Nations people included
agricultural farming, hunting and fishing but the increase
in permanent settlements during the second half of the
20th century led to their growing dependence on store-
bought foods, and an increased dependence on automo-
biles and other energy-saving devices. Since 1998, our
research group has worked closely with the people of the
Six Nations to document CVD risk factors, and subse-
quently to facilitate interventions to reduce these risks for
CVD [2,5-13]. In a previous study we conducted among
the Six Nations adults, 60% of men and 55% of women
were obese (BMI (≥30 kg/m2), compared to 32% and 24%
of non-Aboriginal men and women in Canada respectively
[2]. In addition, the prevalence of glucose intolerance,
dyslipidemia, tobacco use, and CVD was significantly
higher among Six Nations adults compared to age and sex
matched Canadians of European origin [2]. Furthermore,
community level factors such as the built environment, ac-
cess and affordability of healthy foods, and easy access and
affordability of tobacco likely influences the development
of adverse health behaviours [14]. More recently our in-
vestigations have focused on pregnancy and early child-
hood as it represents a time period when chronic disease
prevention may have the greatest impact [15].
Early origins of adiposity and related metabolic changes
Childhood obesity is attributable to environmental changes
leading to increased energy intake and lower physical ac-
tivity. Despite significant population-level changes, there is
increasing evidence that a complex interplay of genetics,
epigenetics, and non-genetic factors also interact to “pro-
gram” a newborn to be more or less prone to develop ex-
cess adiposity depending on the environment to which it is
exposed [16]. The focus of this study is to determine the
key exposures (before, during, and after pregnancy), which
strongly influence the offspring’s weight and adiposity from
birth until early childhood.
Rationale for the creation of an Aboriginal birth cohort
There are numerous birth cohorts underway around
the world, and most are being conducted among white
Caucasian populations. To our knowledge, there are no
Aboriginal birth cohorts in Canada and in addition to the
PIMA Indian studies in the US [17] we only identified one
other birth cohort study being conducted in Indigenous
people in Australia [18]. Creation of an Aboriginal specificbirth cohort is important for three reasons: 1) among chil-
dren and youth of Canada, Aboriginal children have the
highest rate of type 2 diabetes [3], and are therefore are a
high risk population, 2) robust health information derived
from within Aboriginal communities will provide them
with culturally specific information needed to plan preven-
tion programs [19], and 3) multi-ethnic comparisons be-
tween high risk and low risk groups lead to new
understandings of disease pathogenesis as we have dem-
onstrated among adults [11].
Contextual factors which influence adiposity
The Six Nations community suffers from extensive so-
cioeconomic hardship with high rates of unemployment,
low income, and only a small proportion of community
members have post-secondary education [9]. This social
disadvantage is strongly associated with obesity, tobacco
use, diabetes and CVD among the Six Nations people
[9]. Socioeconomic status (SES) also strongly influences
the home environment provided to the newborn and is
likely associated with health behaviours including breast
feeding, dietary intake, tobacco use, and activity patterns.
Low SES is also associated with maternal health post
partum including mental health conditions (i.e. depres-
sion and anxiety), as well as domestic violence [20,21].
Aboriginal women in Canada are much more likely to
have low household incomes, greater social disadvan-
tage, and greater psychosocial stressors compared to
non-Aboriginal women, and there is sparse data regard-
ing social support [22]. It is likely that low SES interacts
with other risk factors, i.e. diet, activity, alcohol intake,
and smoking which together contribute to adverse birth
outcomes and increased infant morbidity [23]. In ABC
we measure key contextual factors (i.e. SES, antenatal
and postpartum depression, domestic violence, and so-
cial support) and will test their association with feeding,
activity and adiposity in the growing offspring.
Genetics and epigenetics
To our knowledge the contribution of common genetic
polymorphisms to the development of adiposity and
cardio-metabolic traits has not been comprehensively in-
vestigated among newborns. Furthermore, the modula-
tion of the genetic effects by in utero characteristics,
postnatal diet, activity, and postnatal rate of weight gain
in relation to the growing offspring’s adiposity has not
been investigated. There is emerging evidence from
model systems and human placentas that early exposure
to environmental factors – including in utero environ-
ment – produce epigenetic modifications leading to
changes in gene expression, metabolic profile, and infant
growth [24]. Maternal malnutrition, overnutrition and
smoking exposure can induce epigenetic modifications
of the fetal genome. The impact of early environmental
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ically studied in humans partly due to technological bar-
riers. However chip-based epigenetic measurements can
now be made with a high degree of precision and repro-
ducibility. Creation of ABC with its longitudinal assess-
ment of nutritional and metabolic risk factors during
pregnancy (i.e. fetal environment), at birth and up to
3 years of age for the index child, provides a unique op-
portunity to characterize how early environmental expo-
sures interact with genetic variants that in turn program
lifelong adverse health trajectories. By studying mothers
and their offspring, and through our participation in
large genetics consortia, we will be able to study gene–
environment interactions on the development of risk
factors and adiposity in early childhood.
Study objectives
Primary objectives:
1. Determine the major antenatal maternal factors
(e.g. pre-pregnancy weight, weight gain, dietary
intake, physical activity, and smoking exposure),
selected paternal factors (e.g. cigarette smoking),
and pregnancy factors (e.g. maternal weight gain,
smoking exposure, glucose intolerance, and
pregnancy-induced hypertension) which are
associated with the newborn’s adiposity and cardio-
metabolic factors at birth, and annually for the first
three years of life.
2. Determine the association between early feeding
practices (i.e. exclusivity of breastfeeding, formula
feeding, type, frequency and duration of breast/
bottle feeding, and growth after weaning), sleep
patterns and activity on newborn’s adiposity, and
related cardio-metabolic factors annually for the first
3 years of life.
3. Determine the impact of the home environment,
including socio-economic status, social support, and
maternal psychosocial factors on newborn’s adiposity
at birth and annually for the first three years of life.
Secondary objectives:
4. To determine if the rate of breastfeeding increases
with a prenatal education and breastfeeding training
focused on a family member or support person.
5. To study the association between selected genetic
variants and epigenetic marks of the mother and
offspring on the offspring’s adiposity and related
cardio-metabolic factors.
6. To investigate the association between maternal diet in
pregnancy, and infant diet with the infant microbiome
at 1 year, and determine the association between the
infant microbiome and child health outcomes.7. To determine if there are differences in birth weight
and adiposity (corrected for gestational age and sex)
comparing Aboriginal newborns to an existing
cohort of white Caucasian and South Asian
newborns in Canada.
8. To qualitatively explore grandmothers’ beliefs
regarding optimal health behaviours for women
during the perinatal period, to determine how these
compare to evidence-based knowledge about health
behaviours and to identify opportunities for
knowledge translation interventions.
Design/methods
We propose to recruit 300 Aboriginal pregnant mothers
and their newborns from the Six Nations Reserve and fol-
low them prospectively to the age of 3 years. Approval was
received from the McMaster/Hamilton Health Sciences
Research Ethics Board (REB) on April 19, 2012 as well as
the Six Nations Band Council REB on May 22, 2012.
Inclusion criteria
Women of Aboriginal ancestry who are pregnant.
Exclusion criteria
Women who conceived the fetus using artificial methods
including in-vitro fertilization or intrauterine insemin-
ation, women carrying more than one fetus, surrogate
mothers, women who suffer from severe chronic medical
conditions including active cancer, severe infectious dis-
eases including HIV, hepatitis B or C, or who are VDRL
positive, will be excluded (Table 1).
Data collection
Stage I: Antenatal data
Pregnant mothers are recruited through self referral,
or referral to the study from local health care providers
(midwives, nurses, primary care physicians, obstetri-
cians). A log of all interested subjects is kept, and the
main reasons for exclusion or refusal to participate is
recorded. At the baseline visit, between 24–28 weeks of
pregnancy, information on age, parity, medical and preg-
nancy history, cigarette smoking exposure of mother,
father and family members, drugs and alcohol exposure,
family structure (i.e. marital status, and number of chil-
dren in the house), community of birth, mother tongue,
cultural practices, psychosocial characteristics, as well as
socioeconomic factors (i.e. household income, education,
and employment) is collected (Table 2). The pregnant
mother also has a number of anthropometric measure-
ments taken during this visit. A digital scale is used to
record body weight to the nearest 100 g. Height is mea-
sured using a stadiometer to the nearest 1 cm and mid
upper arm circumference to the nearest 0.1 cm using a
plastic measuring tape. Maternal BMI is calculated using
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
Women < 40
years old
Women who conceived the fetus using artificial








Women who suffer from severe chronic medical
conditions including active cancer, severe infectious
diseases including HIV, hepatitis B or C, or who are
VDRL positive
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pregnancy weight is recorded. Skinfold thickness (triceps
and subscapular) is measured to the nearest 0.2 mm,
using skinfold calipers (Holtain, UK), for the prediction
of body fat using prediction equations [25]. Systolic and
diastolic blood pressure is measured using an automated
BP monitor (OMRON Intelli Sense, Model HEM-757).
All ultrasound reports are obtained and used to establish
gestational age and to assess fetal growth characteristics.
Dietary and Physical Activity assessment: We have
previously developed and validated a FFQ for Aboriginal
people in Canada [8], which is administered during the
second trimester visit, as well as at 6 months and 1 year
postpartum visits. Information on maternal activity dur-
ing pregnancy is collected for activities in 5 domains –
occupational, discretionary exercise, household chores,
sedentary activities, hobbies and sleep. Maternal seden-
tary behaviours will include daily screen time (computer,
television, video games). Activity and sedentary behav-
iour are collected at baseline and at each annual visit.
Psychosocial Assessment: SES is assessed by recording
annual household income, employment, education and
marital status. Information is gathered about chronic
stressors in the home, workplace and community and
stressful life events. Adequacy of social support to the
mother is measured using a questionnaire to evaluate
the emotional, instrumental, informational, and appraisal
components of social support. Depression in the mother
is assessed by the Kessler-10 scale (K-10) which is a 10-
item scale with five response categories ranked on a 5-
point scale [26]. Intimate partner violence is assessed
using the 2-item Woman Abuse Screening Tool short
version [27]. All psychosocial questionnaires are admin-
istered at the baseline visit, at 6 months postpartum and
annually thereafter.
Laboratory Assessments: The classification of maternal
glycemic status is critical to determine glucose-metabolic
status during the second trimester of pregnancy. All non-
diabetic mothers will undergo the 75-gram oral glucose
tolerance test (OGTT) between 24–28 weeks of gestation.
This test is chosen to avoid the high false negative rateusing the 50 gram glucose challenge test among some
non-white populations [28]. Three blood samples are col-
lected: fasting, 60, and 120 minutes [29]. Some local ana-
lysis are performed immediately (i.e. glucose, complete
blood count) using standardized assays, and the remainder
are processed, shipped and stored at the Clinical Trials
Clinical Research Laboratory (Hamilton Health Sciences)
for future analysis (i.e. lipids, adiponectin, leptin, insulin,
the buffy coat for DNA extraction).
Stage 2: Birth
At the time of birth, details including birth outcomes
for the mother and baby (e.g. type of delivery, APGAR
scores, problems during delivery, length of stay) are col-
lected. A cord blood sample for biochemistry (i.e. glu-
cose, insulin, lipids, adiponectin, leptin), DNA and
additional serum and plasma aliquots for future analysis
is collected from each baby. Newborn’s physical charac-
teristics including birth weight, skin fold thickness,
length, abdominal, head, and arm circumference and
blood pressure are measured within 72 hours after birth.
Assessment of Body Composition in Newborn and
Infants: In infants, percent body fat can be estimated by a
prediction equation derived from four skinfold measures
[30]. This method has been validated against DXA in new-
borns [31] and among children aged 4–10 years [32]. The
correlation coefficient of equation-estimated percent body
fat in newborns compared to DXA is 0.92 and among chil-
dren aged 4–10 years, 0.88 [31]. The reliability of these es-
timates range from 99.5 to 99.8% [30-32]. In the ABC all
newborns and infants will have skinfold thickness mea-
sured (biceps, triceps, subscapular, and suprailiac) at birth
and at each annual visit.
Stage 3: Follow-up after Delivery:
After delivery, mother and child dyad are further
followed by e-mail or telephone at 6 weeks and 6 months
to collect information on the infants weight and feeding
practices, and in a face to face visit at 1, 2, and 3 years
after birth. An annual blood sample will be collected
from the infant to measure the complete blood count to
screen for iron deficiency anemia, and for analysis of
glucose, insulin, and lipids. We offer use of a secured
study website for participants to enter the baby’s weight,
length, and head circumference monthly recorded at
their routine well baby visits.
Assessment of growth and body composition of the
infant: Anthropometric measurements of the child are
made annually. Infants are weighed to the nearest 10 g
on an electronic scale; length is measured on an
infantometer. Head, chest and mid upper arm circumfer-
ence of the baby are measured to the nearest 0.1 cm
using a plastic measuring tape. Skinfold measurements
are measured to the nearest 0.2 mm, using skinfold cali-
pers (Holtain, UK) for prediction of body composition.
All measures are done by trained personnel, and inter-
Table 2 Proposed measures and timing of measures in ABC
Measures Antenatal visit1 Birth visit 6 months post delivery (telephone) 1 year visit 2 year visit 3 year visit
Demographics - X
Age X X1 X1 X1
HCN X X1,3 X1,3 X1,3
Address/Postal Code X X1 X1 X1
Family Doctor - Info X X1 X1 X1
Midwife/ObGyn Info X
Expected Delivery Date X
Medical History X
Diabetes X X1
Increased blood pressure X X1
Increased cholesterol X X1
Other major medical history X X1
Family History X
Medications Used X X1
Past Pregnancy Info X
GTPAL X
Still Births X
Past Gest. DM X
Pre-Eclampsia X
Low Birth Weight X
Premature Birth X
Social Determinants X
Years Living on the Reserve X
Place of Birth X
Religious Practices X
Annual Household Income X X1 X1 X1
Occupation X X1 X1 X1
Marital Status X X1 X1 X1
Education X X
Social Support X X1 X1 X1
Domestic Violence X X1 X1 X1
Depression X X1 X1 X1 X1
Health Behaviours
Cigarette Exposure X X X X
Diet/Infant feeding X X3 X3 X3 X3
Activity/Sedentary Behaviours X X3 X3 X3 X3
Physical Exam X X X X
Blood Pressure X X2 X3 X3 X1,3
Height/Length X X2 X3 X3 X3 X1,3
Weight X X2 X3 X1,3 X1,3 X1,3
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Table 2 Proposed measures and timing of measures in ABC (Continued)
Waist and Hip Circumference X X2 X3 X3 X1,3
Skin Folds X X2 X3 X3 X1,3




Glucose X2 X3 X3 X3
75 g OGTT (0, 60, 120 min) X
Insulin X X2 X3 X3 X3
Adiponectin X X X X X
Leptin X X2 X X X
Lipid Profile X X2 X3 X3 X3
CBC X2 X3 X3 X3
Aliquots for Future Analysis X X2 X3 X3 X3
DNA Long-term Storage X X2
Birth Visit
Type of Delivery X




APGAR scores (1 and 5 min) X
Adverse outcomes X
Placenta & Cord Blood X
Stool X3
Breastmilk X4
1: All measurements taken in the mother, 2: Measurements taken in newborn at birth, 3 Measurements taken in infant, 4: Collected from mother at 6 weeks.
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length which is measured using a length board until
18 months of age, and height will be measured using a
Harpenden stadiometer after 18 months of age. Weight
is measured with an electronic scale.
Breastfeeding, Infant diet, and Activity Assessment: In-
formation on infant feeding practices is collected at
6 weeks and 6 months, and annually by interviewing the
mother of the infant/child. Information on initiation of
breastfeeding, exclusivity of breastfeeding, duration of
breast feeding, and introduction of complementary foods
is collected. A validated Infant Feeding Form is used and
is a closed ended questionnaire with information about
breastfeeding, other feeds and complementary feeds
taken during last 7 days [33]. Among mothers who are
breastfeeding, breast milk is collected at 6 weeks post-
partum. The samples are collected, frozen and stored for
future analysis of macronutrient content and environ-
mental toxins such as persistent organic pollutants [34].The goal is to evaluate the association of breast milk
content with adiposity and related metabolic phenotypes.
Furthermore, an intervention to promote breastfeeding
in the community is being pilot tested as a sub-study.
The primary objective of the intervention study is to de-
termine if prenatal training in breastfeeding education of
a family member or support person improves the rate of
any breastfeeding at 6 weeks post-partum. At age one
and 3 years, the mother will complete a 24-hour dietary
recall for the child. An activity assessment in the grow-
ing child at each annual visit will be performed using a
24-hour activity recall developed and validated for use in
young children.
Infant microbiome: Stool will be collected from infants
at age 1 year. Prior to the annual visit, a stool collection
kit will be mailed to families. The kit will contain diaper
liners, collection bag and instructions. A diaper liner will
be placed in the child’s diaper until stool has been de-
posited in the liner. The diaper liner with specimen will
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samples will be collected at the annual visit and frozen
for future analysis.
Genetic, Methylation, Gene Expression, Placenta Analysis:
Mother’s and newborn’s DNA is extracted from the buffy
coats and used in future genetic association and methyla-
tion studies. RNA from leukocytes are extracted from
PaxGene tubes, which are collected from newborns at birth.
A 1 cm× 1cm biopsy of the placenta is collected from all
consenting mothers and stored in RNAlater to enable fu-
ture placental gene expression and methylation analysis.
Grandmother’s Interviews: Grandmothers of Aborigi-
nal ancestry are invited to participate in an individual
semi-structured qualitative interview, ensuring that their
beliefs are captured using a culturally-sensitive lens. The
interview questions are designed to elicit grandmother’s
beliefs regarding optimal health behaviours for a woman
(1) before pregnancy, (2) during pregnancy, (3) the first
6 weeks postpartum, and (4) optimal behaviours for the
family with the new baby in the first year of life. Ques-
tions probe their beliefs about diet and feeding practices,
sleep, activity, smoking, alcohol, social support, mental
health, and intimate partner relationships. The qualita-
tive interviews are analyzed using a constant comparison
technique to identify emergent themes, concepts and
linkages and used to develop a theory. Grandmother’s
beliefs will then be compared to existing evidence-based
knowledge and the results of the ABC study and used to
inform future education initiatives.
Statistical Considerations:
Statistical Power: We estimate that 300 mother-baby
dyads will provide high power to address the primary
objectives of this study. The primary outcome of the
study is newborn adiposity measured by skin fold thick-
ness from 4 locations (triceps, biceps, subscapular, and
suprailiac).
Primary Objectives:
Objectives 1–3: For continuous predictors, with 300
newborns we have >80% power to detect an absolute
change in percent body fat of 0.82 per 1 SD increase in a
given predictor (i.e. maternal weight gain) (two-tailed
alpha = 0.05), and we have >90% power to detect an ab-
solute change of 0.96 in percent body fat. For categorical
predictors (i.e. maternal gestational diabetes), with 300
newborns we have >80% power to detect an absolute dif-
ference in percent body fat of 2.53% when at least 20%
have the exposure of interest. There is also sufficient
power to detect an absolute difference of 3.24% body fat
between top and bottom quartile group extremes (e.g.,
maternal glucose values or dietary factors). Similar high
power is present to test postnatal factors against change
in adiposity from birth to age 3 years.Secondary objectives:
Objective 4 Breastfeeding: Based on available literature
amongst Aboriginal women in Canada and input from
the lactation consultant from the Six Nations commu-
nity the usual rate of any breastfeeding in the control
group is expected to be 50% at 6 weeks post-delivery.
We anticipate our intervention will increase this to 70%
and have powered the study to detect a 20% absolute
increase.
Objective 5 Genetics: We anticipate that the minor al-
lele frequency (MAF) of SNPs of selected candidate
genes will be similar to the MAFs we have observed in
other cohorts [35]. To study associations of selected can-
didate SNPs with their respective quantitative traits we
anticipate requiring approximately 1,000 babies of Abo-
riginal origin to have high power. Expansion of ABC to
other Aboriginal reservations to achieve this objective is
planned. We will also include our 300 participants data
in larger genetic consortia of birth cohorts to enable the
study of gene-environmental interactions.
Objective 6 Diet and microbiome: The infant
microbiome diversity at 1 year will be tested for associ-
ation with infant outcomes at age 3 years. The compos-
ition of the infant microbiome will be compared between
exposure groups comparing those exposed to maternal
gestational diabetes, exclusive breast feeding, and treat-
ment of the infant with antibiotics in the first year of life.
The infant microbiome will also be assessed as a potential
determinant of child adiposity and insulin resistance at
age 3 years. With 300 samples, there will be considerable
sample size/power to detect differences in bacterial com-
position and diversity at infants 1 year of age based on ex-
posure group, compared to prior sample sizes of
microbiome studies [36-39].
Objective 7 Birthweight, adiposity, and ethnicity:
Comparing body fat percentage in Aboriginal newborns
to white Caucasian and South Asian newborns in
Canada from the FAMILY [40] and START [41] cohorts
respectively, we will calculate body fat from the skin fold
thickness measures, and after adjusting for differences in
gestational age, we will compare the percent body fat
per kg of birth weight. Normalizing body composition
measurements (e.g. skinfold thickness and body fat) by
birth weight has been used as a standard approach to
make comparisons across groups of infants of varying
body size, including across ethnic categories and sex
[42,43]. The estimate of percent body fat in the FAMILY
[40] study among white Caucasians (n = 868) is 17% (SD:
4.3%) or 5.1% (1.5%)/kg of birth weight, and it is
expected to be 6%/kg birth weight in South Asians.
Therefore with 300 Aboriginal newborns, we will have >
80% power to detect an absolute difference in percent
body fat/kg birth weight of at least 0.30%, and we have
similar high power to detect absolute differences in birth
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newborns from other ethnic groups. A difference of
0.30%/kg is clinically important as this difference was as-
sociated with an increase in insulin resistance of 0.8
units in HOMA in an adolescent cohort, which is
equivalent to a 20% increase in risk of incident diabetes
after 10 years [44].
Objective 8 Grandmothers’ study: Non-probabilistic
sampling of 20 to 30 grandmother participants is antici-
pated, however study enrolment will continue until data
saturation is reached. Interviews will be recorded and
transcribed verbatim. The text of the interviews will be
imported into NVivo-9 software for coding. Data will be
analyzed using thematic analysis. Multiple layers of coding
will be performed including open, focused, axial and the-
matic coding. The data will be closely adhered to with sen-
sitivity to emerging subthemes and when saturation is
reached, no further interviews will be held. After identifi-
cation of themes, participants will be invited to have a final
interview where the themes will be presented back to
them for member-checking and triangulation.
Statistical Analysis: Descriptive statistics characteriz-
ing maternal and newborn characteristics will be gener-
ated. Continuous variables will be reported as means
and SD for the normally distributed variables otherwise
median and inter-quartile ranges will be reported. Cat-
egorical variables will be reported using percentages.
Normality of the variables will be examined and appro-
priate transformations applied if required. All analysis
will be considered statistically significant at 5% level. As
an example of the multiple sources of data we will ac-
crue from this study a detailed statistical analysis plan
for the Aboriginal cohort is provided. We propose to
study, the contributions of maternal, newborn, and
post-natal factors to the offspring’s adiposity at birth,
and the change over time of body fat in the offspring.
To do so we will study the effect of multiple types of
data (i.e. maternal characteristics such as diet, hyper-
tension, micronutrient status, maternal weight gain,
presence of gestational diabetes), infant characteristics
(gestational age, feeding type, amount, duration,
microbiome profile), certain contextual factors (i.e. so-
cioeconomic status), and in future selected genetic vari-
ants (i.e. using a gene score of all known common
genetic variants associated with adiposity) on the out-
come of adiposity, and change in body fat from birth
until 3 years. Our goal will be to identify those determi-
nants and their interactions, which predict change in
adiposity as the child grows. A two-staged analytic plan
will be used to accomplish this goal. Stage 1: Examining
the strongest influences (maternal and newborn charac-
teristics) on adiposity: First, the relationship within each
group of determinants (maternal and newborn) and adi-
posity will be assessed using multi-level growth curvemodels [45]. Measurement of adiposity over time for
the same children will be modeled to show trajectories
or slopes (linear or non-linear patterns) as a function of
strongly associated and significant influences identified
within each factor group (i.e. maternal, infant, genetic).
Potential covariates (i.e. contextual factors) will be ex-
amined to identify those that are highly correlated with
other potential covariates; and only those that have an
independent influence will be included. Covariates
known to be associated with adiposity within each fac-
tor group will be included a priori and then other covar-
iates will be identified using a backward elimination
technique. Once a reasonable predictive model has been
chosen, all excluded covariates will be added into the
model one at a time to identify any missing con-
founders. We will also apply a stepwise regression ap-
proach to assess robustness of our modeling strategy.
Previous studies in which models are validated in inde-
pendent data sets have shown that a fitted regression
model is likely to be reliable when the number of inde-
pendent predictors is less than the total sample size di-
vided by 20 [46].
Discussion
There is an urgent need to understand maternal and
child factors that underlie the early development of adi-
posity and type 2 diabetes in Aboriginal people. The in-
formation generated from this cohort will increase our
understanding of the contribution of pre and post natal
factors to childhood overweight/obesity and type 2 dia-
betes, and assist the Six Nations community in develop-
ing interventions to prevent early adiposity in Aboriginal
children. We anticipate this study will be expanded to
include other Aboriginal communities across Canada.
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